| Descriptor English: | Chemokine CCL19 | ||||||
| Descriptor Spanish: |
Quimiocina CCL19
| ||||||
| Descriptor Portuguese: | Quimiocina CCL19 | ||||||
| Descriptor French: | Chimiokine CCL19 | ||||||
| Entry term(s): |
CCL19 Chemokine CCL19, Chemokine Chemokine, CCL19 Chemokine, EBI1-Ligand Chemokine, ELC Chemokine, Exodus-3 EBI1 Ligand Chemokine EBI1-Ligand Chemokine ELC Chemokine Epstein Barr Virus Induced Molecule 1 Ligand Chemokine Epstein-Barr Virus-Induced Molecule 1 Ligand Chemokine Exodus 3 Chemokine Exodus-3 Chemokine MIP 3beta MIP-3beta Macrophage Inflammatory Protein 3 beta Macrophage Inflammatory Protein 3-beta |
||||||
| Tree number(s): |
D12.644.276.374.200.110.870 D12.644.276.374.200.600.870 D12.776.467.374.200.110.870 D12.776.467.374.200.600.870 D23.125.300.110.870 D23.125.300.600.870 D23.469.200.110.870 D23.469.200.600.870 D23.529.374.200.110.870 D23.529.374.200.600.870 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D054415 | ||||||
| Scope note: | A CC-type chemokine with specificity for CCR7 RECEPTORS. It has activity towards T LYMPHOCYTES and B LYMPHOCYTES. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Public MeSH Note: | 2008; CCL19 CHEMOKINE (now CHEMOKINE CCL19) was indexed under CHEMOKINES CC 1998-2007 & under CHEMOKINES 1997 |
||||||
| History Note: | 2008(1998) |
||||||
| DeCS ID: | 52765 | ||||||
| Unique ID: | D054415 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2008/01/01 | ||||||
| Date of Entry: | 2007/07/09 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
|
Chemokine CCL19
- Preferred
| Concept UI |
M0277173 |
| Scope note | A CC-type chemokine with specificity for CCR7 RECEPTORS. It has activity towards T LYMPHOCYTES and B LYMPHOCYTES. |
| Preferred term | Chemokine CCL19 |
| Entry term(s) |
CCL19 Chemokine CCL19, Chemokine Chemokine, CCL19 Chemokine, EBI1-Ligand Chemokine, ELC Chemokine, Exodus-3 EBI1 Ligand Chemokine EBI1-Ligand Chemokine ELC Chemokine Epstein Barr Virus Induced Molecule 1 Ligand Chemokine Epstein-Barr Virus-Induced Molecule 1 Ligand Chemokine Exodus 3 Chemokine Exodus-3 Chemokine MIP 3beta MIP-3beta Macrophage Inflammatory Protein 3 beta Macrophage Inflammatory Protein 3-beta |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
